Treatment Considerations for the Truvada drug...

Every drug has its side effects, these are possible questions that could arise from taking this medication to cure or prevent HIV.

If you are currently on HIV meds, you may want to discuss these questions with your healthcare provider:

• How many times a week do you find it difficult to take your HIV meds?
• How many times a day do you need to take each of your HIV meds?
• Is there a particular time of day that's more difficult to take your HIV meds?
• Do food restrictions interfere with taking your HIV meds on time?
• Are there any side effects that you experience on your current HIV meds?

Talk to your doctor if you are looking for an HIV med that:

• Can be taken once a day as part of a complete regimen
• Can help lower your viral load and help get you to undetectable (<400 copies/mL)
• Can help increase CD4 cell count
• Can be taken with or without food

Things to talk with your healthcare provider about before starting TRUVADA
The best way to know if TRUVADA is right for you is to talk with your healthcare provider. Here are some additional questions that may help guide your discussion:

• Are you pregnant or are planning to become pregnant?
• Are you breastfeeding?
• Do you have kidney problems, or are undergoing kidney dialysis?
• Do you have bone problems?
• Do you have liver problems, including hepatitis B virus infection?

It is also important to talk to your doctor about any other medications you may be taking.
Click here to find answers to other frequently asked questions about TRUVADA. These questions provide a full list of considerations and information to guide discussions with your healthcare provider when determining if TRUVADA is right for you.
Next: Important Safety Information
Patients should read the Patient Information, including "What is the most important information I should know about TRUVADA?". It is important that you discuss your treatment options and any questions that you may have with your healthcare provider.

*Synovate Healthcare Data; U.S. HIV Monitor, Q1, 2010.